ArticleMolecular genetics and metabolism reports2025

Efficacy results from a 12-month double-blind randomized trial of arimoclomol for treatment of Niemann-Pick disease type C (NPC): Presenting a rescored 4-domain NPC Clinical Severity Scale.

Eugen Mengel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.